| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/07/2011 | US20110165163 Identification of a conserved inner core oligosaccharide of moraxella catarrhalis lipopolysaccharide as a vaccine antigen |
| 07/07/2011 | US20110165159 Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt or pbsc transplant |
| 07/07/2011 | US20110165154 Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
| 07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/07/2011 | US20110165123 5' triphosphate oligonucleotide with blunt end and uses thereof |
| 07/07/2011 | US20110165122 Method for targeted and sustained antiviral therapy |
| 07/07/2011 | US20110165121 Use of pegylated type iii interferons for the treatment of hepatitis c |
| 07/07/2011 | US20110165098 Methods to prevent cytotoxicity using n-acetyl-cysteine |
| 07/07/2011 | US20110165096 Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same |
| 07/07/2011 | US20110165091 Method and composition for delivery of medicants to animals |
| 07/07/2011 | US20110165090 Method and composition for delivery of medicants to animals |
| 07/07/2011 | US20110165081 Psma antibodies and uses thereof |
| 07/07/2011 | US20110165071 Methods Of Treating Cancer |
| 07/07/2011 | US20110165067 Carbohydrate functionalized catanionic surfactant vesicles for drug delivery |
| 07/07/2011 | US20110165066 Interleukin-13 binding proteins |
| 07/07/2011 | US20110165063 Il-1 binding proteins |
| 07/07/2011 | CA2789196A1 Anti-iga1 antibody |
| 07/07/2011 | CA2786090A1 Interferon analogs |
| 07/06/2011 | EP2341348A1 Methods for detecting cross beta structure comprising proteins with crossbeta structure binding compounds. |
| 07/06/2011 | EP2341143A1 OX2 receptor homolog |
| 07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
| 07/06/2011 | EP2341078A2 Monoclonal antibody against rhesus D |
| 07/06/2011 | EP2341076A2 Thymic stromal lymphopoietin (TSLP) antibodies and uses thereof |
| 07/06/2011 | EP2341068A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 07/06/2011 | EP2341063A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/06/2011 | EP2341062A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
| 07/06/2011 | EP2341050A1 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 07/06/2011 | EP2341049A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as PTPASE 1B inhibitors |
| 07/06/2011 | EP2341045A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid (acyloxy)alkyl or ((alkoxycarbonyl)oxy)alkyl ester as SPLA2 inhibitor |
| 07/06/2011 | EP2340847A2 Cell populations having immunoregulatory activity, method for isolation and uses |
| 07/06/2011 | EP2340830A2 Hepatitis C Virus Inhibitors |
| 07/06/2011 | EP2340822A1 Acylated 4-amidino and 4-guanidinobenzylamines for inhibiting plasma kallikreins |
| 07/06/2011 | EP1587834B1 Uses of il-23 mammalian cytokine; related reagents |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
| 07/06/2011 | EP1173484B1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
| 07/06/2011 | EP1146906B1 Mucosal delivery system |
| 07/06/2011 | CN1988899B The euphorbia lunulate bge extractant and production method and use thereof |
| 07/06/2011 | CN1875748B Application method of lactoferritin in food |
| 07/06/2011 | CN1838965B Drug for cancer therapy |
| 07/06/2011 | CN102119175A Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology |
| 07/06/2011 | CN102119174A Compositions and methods of use for therapeutic antibodies |
| 07/06/2011 | CN102119030A Antihistamine and antihistamine-like nasal application, products, and method |
| 07/06/2011 | CN102115748A Danio rerio B-lymphocyte activating factor (zBAFF) cDNA (complementary deoxyribonucleic acid), and cloning method and application thereof in recombination |
| 07/06/2011 | CN102115747A cDNA (complementary deoxyribonucleic acid) of horse tumor necrosis factor superfamily member 13B (horse TNFSF 13B), and cloning method, recombination and application thereof |
| 07/06/2011 | CN102115482A Annatto oligosaccharide, preparation method and usage thereof |
| 07/06/2011 | CN102114218A Traditional Chinese medicine for tonifying kidney, strengthening yang and resisting fatigue and preparation method thereof |
| 07/06/2011 | CN102114173A Medicament for treating allergic rhinitis and preparation method thereof |
| 07/06/2011 | CN102114163A Traditional Chinese medicine for treating Henoch-Schonlein purpura nephritis |
| 07/06/2011 | CN102114112A Effervescent tablet for improving immunity and preparation method thereof |
| 07/06/2011 | CN102114067A Compound oviductus ranae granules and application thereof |
| 07/06/2011 | CN102114032A Nutritional composition for improving immune function of poultry |
| 07/06/2011 | CN101703744B Chinese medicinal composition for treating palpitation and shortness of breath and preparation method thereof |
| 07/06/2011 | CN101669926B Liquid preparation for dosing nasal cavities and method for making the same |
| 07/06/2011 | CN101637605B Application of Dachaihu granules in preparation of medicaments for treating hives |
| 07/06/2011 | CN101628059B Drug composite and drug preparation containing drug composite |
| 07/06/2011 | CN101627998B Loratadine-ambroxol pharmaceutical composite and liposome solid preparation thereof |
| 07/06/2011 | CN101585805B Preparation method of an antiallergic agent fexofenadine hydrochloride |
| 07/06/2011 | CN101580539B Polypeptide for inducing CD4<+>CD25<+> regulatory T cells and application |
| 07/06/2011 | CN101406493B Microsphere for injection of Cordyceps sinensis and preparation method thereof |
| 07/06/2011 | CN101119986B Optically active tetrahydronaphthalene derivative |
| 07/05/2011 | US7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/05/2011 | US7973039 3-(1,3-benzodioxol-5-yl)-1-({[4-(4-fluorophenyl)-1-piperazinyl]sulfonyl}methyl)-2-propynyl(hydroxy)formamide; analgesics, anticarcinogenic agents, antiarthritic agents; matrix metalloproteinase inhhibitors |
| 07/05/2011 | US7973024 24-sulfoximine vitamin D3 compounds |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/05/2011 | CA2459172C Bicyclic compound, production and use thereof |
| 07/05/2011 | CA2446971C Use of 3-position cyclosporin derivatives for hair growth |
| 07/05/2011 | CA2427475C Purification of hbv antigens for use in vaccines |
| 07/05/2011 | CA2401491C Ccr4-binding antibody and diagnostic and therapeutic uses thereof |
| 07/05/2011 | CA2210656C Receptor specific transepithelial transport of immunogens |
| 06/30/2011 | WO2011079249A2 Use of vitamin d glycosides and sulfates for treatment of disease |
| 06/30/2011 | WO2011079051A1 Fused heteroaromatic pyrrolidinones as syk inhibitors |
| 06/30/2011 | WO2011078990A1 Hydrogels comprising hyaluronan and at least one t cell induction agent |
| 06/30/2011 | WO2011078795A1 Bridged morpholino substituted purines |
| 06/30/2011 | WO2011078778A1 Method for assessing the sensitisation capability of a compound |
| 06/30/2011 | WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | WO2011078367A1 Emulsion composition |
| 06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
| 06/30/2011 | WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same |
| 06/30/2011 | WO2011077587A1 Composition for inhibiting allergic diseases |
| 06/30/2011 | WO2011076878A1 Aminoalkylpyrimidine derivatives as histamine h4 receptor antagonists |
| 06/30/2011 | WO2011076007A1 Lactobacillus paracaseistrain lt12 as anti-allergy agent |
| 06/30/2011 | WO2011075823A1 Immunogenic compositions |
| 06/30/2011 | WO2011075822A1 Immunogenic compositions and related methods |
| 06/30/2011 | WO2011075784A1 Compounds, preparations and uses thereof |
| 06/30/2011 | WO2010138194A3 Immunomodulatory agent-polymeric compounds |
| 06/30/2011 | US20110162095 TNFSF Single Chain Molecules |
| 06/30/2011 | US20110160845 Drug delivery system and method of manufacturing thereof |
| 06/30/2011 | US20110160309 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
| 06/30/2011 | US20110160243 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 06/30/2011 | US20110160235 Triazolyl tropane derivatives |
| 06/30/2011 | US20110160232 Certain chemical entities and therapeutic uses thereof |
| 06/30/2011 | US20110160215 Substituted Triazolo-Pyrazine Compounds |
| 06/30/2011 | US20110160213 Pharmaceutical compositions for the treatment of inflammatory and allergic disorders |
| 06/30/2011 | US20110160207 Heterocyclic amide compounds useful as kinase inhibitors |
| 06/30/2011 | US20110160205 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |